An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)
Clinical trial NCT03823625 · UNKNOWN
Trial details
- NCT number
- NCT03823625
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2021-02-28
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.